Trials suggest new drug may offer women with terminal breast cancer more time

Charities have welcomed the "outstanding" results of a clinical trial which shows that a drug for a type of incurable breast cancer delays the disease getting worse.

Charities have welcomed the "outstanding" results of a clinical trial which shows that a drug for a type of incurable breast cancer delays the disease getting worse.

Olaparib (Lynparza) can give women living with BRCA-mutated advanced breast cancer significant extra time before their disease progresses, the study found.